Start Time: 08:30 January 1, 0000 9:00 AM ET
Delcath Systems, Inc. (NASDAQ:DCTH)
Q3 2022 Earnings Conference Call
November 08, 2022, 08:30 AM ET
Company Participants
Gerard Michel - CEO
Anthony Dias - VP of Finance
Johnny John - VP, Clinical Development & Medical Affairs
Kevin Muir - VP, Commercial Operations
David Hoffman - General Counsel, Corporate Secretary and Chief Compliance Officer
Conference Call Participants
Sam Eiber - BTIG
Scott Henry - ROTH Capital
Yale Jen - Laidlaw & Company
Bill Maughan - Canaccord Genuity
Operator
Good day, and welcome to the Delcath Systems Third Quarter 2022 Financial Results Conference Call. All participants will be in listen-only mode. [Operator Instructions]. After today’s presentation, there will be an opportunity to ask questions. [Operator Instructions]. Please note today’s event is being recorded.
I would now like to turn the conference over to David Hoffman, Delcath’s General Counsel. Please go ahead.
David Hoffman
Thank you. And once again welcome to Delcath Systems third quarter 2022 earnings call. With me on the call are Gerard Michel, Chief Executive Officer; Dr. Johnny John, Senior Vice President of Medical Affairs and Clinical Development; Kevin Muir, Vice President of Commercial Operations; and Anthony Dias, Vice President of Finance.
I'd like to begin the call by reading the Safe Harbor statement. This statement is made pursuant to the Safe Harbor for forward-looking statement described in the Private Securities Litigation Reform Act of 1995. All statements made on this call, with the exception of historical facts, may be considered forward-looking statements within the meaning of Section 27(a) of the Securities Act of 1933 and Section 21(e) of the Securities Exchange Act of 1934. Although the company believes that expectations and assumptions reflected in these forward-looking statements are reasonable, it makes no assurance that such expectations will prove to have been correct. Actual results may differ materially from those expressed or implied in forward-looking statements due to various risks and uncertainties.
For a discussion of such risks and uncertainties which could cause actual results to differ from those expressed or implied in the forward-looking statements, please see Risk Factors detailed in the company’s annual report on Form 10-K, those contained in subsequently filed quarterly reports on Form 10-Q, as well as in other reports that the company files from time-to-time with the Securities and Exchange Commission. Any forward-looking statements included in this earnings call are made only as of the date of this call. We do not undertake any obligation to update or supplement any forward-looking statements to reflect subsequent knowledge, events or circumstances.